According to a recent LinkedIn post from OpenEvidence, the company’s platform is now handling more than 1 million physician questions per day, which the post suggests represents usage by over half of practicing physicians in the U.S. The post highlights that OpenEvidence is positioned as a critical, real-time decision-support tool where downtime or latency could have direct clinical implications.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The same post emphasizes OpenEvidence’s reliance on Baseten as an inference infrastructure partner to maintain availability and responsiveness during high‑stakes clinical decision making. For investors, the described usage scale and operational dependence on robust AI infrastructure suggest a growing, recurring demand profile, potential pricing power in clinical decision support, and heightened importance of technical reliability as a competitive differentiator.

